Skip to main content

Table 2 18F-FDG intensity (SUVmax) variation after one course of chemotherapy. (on lines 4 and 6, p represents the p-value based on Wilcoxon’s signed-rank test or the paired Student’s t-test for before/after variation; in the last column, p is the p-value based on Welch’s ANOVA or Kruskal-Wallis test for the differences across the three groups of weight variation)

From: A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients

 

Overall population (n = 109)

GAIN (n = 32)

STABLE (n = 66)

LOSS (n = 11)

p

SUVmax before: mean (SD)

1.16 (0.88)

1.31 (1)

1.14 (0.86)

0.86 (0.38)

0.201

SUVmax after: mean (SD)

1.02 (0.9)

0.97 (0.87)

1.08 (0.98)

0.8 (0.24)

0.537

ΔSUVmax (SD)

kg

- 0.14 (0.85)

- 0.34 (0.98)

- 0.06 (0.85)

- 0.05 (0.23)

0.322

p

0.022

0.022

0.254

0.898

%

−4.38 (34.07)

- 13.42 (35.82)

−0.35 (34.45)

−2.27 (21.6)

0.28

p

0.056

0.042

0.399

0.735